These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9175376)

  • 21. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Simple lung function studies; assessment of effects].
    Duiverman EJ
    Tijdschr Kindergeneeskd; 1983 Dec; 51(6):199-207. PubMed ID: 6670093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency room assessment and adrenaline treatment of patients with acute asthma of different severity.
    Limthongkul S
    J Med Assoc Thai; 1989 Jun; 72(6):338-45. PubMed ID: 2778423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical signs in childhood asthma.
    Commey JO; Levison H
    Pediatrics; 1976 Oct; 58(4):537-41. PubMed ID: 972794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of wheezing to the severity of obstruction in asthma.
    Shim CS; Williams MH
    Arch Intern Med; 1983 May; 143(5):890-2. PubMed ID: 6679232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peak flow measurement].
    Willroth PO; Karwath R
    Z Erkr Atmungsorgane; 1990; 174(1):73-9. PubMed ID: 2184612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia.
    Al-Ali MK; Howarth PH
    Saudi Med J; 2001 Mar; 22(3):249-53. PubMed ID: 11307112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of the peak flow in ambulatory asthmatic patients].
    Pernas Gómez M; Fernández de Castro J; Bacallao Gallestey J; Almirall Collazo JJ
    Allergol Immunopathol (Madr); 1985; 13(4):327-30. PubMed ID: 4083231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
    Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
    Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic obstructive pulmonary disease patients undergoing home oxygen therapy: a study of clinical parameters, nutritional status and ambulatory capacity].
    Frey JG; Rochat T; Pichard C; Dousse N; Janssens JP; Tschopp JM
    Rev Mal Respir; 1998 Feb; 15(1):69-78. PubMed ID: 9551517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of forced expiratory volume (FEV 1) and maximal peak expiratory flow within the scope of routine diagnosis in general practice].
    Tönies H; Capek J; Hecht H; Rothe G; Sellner C; Kummer F
    Wien Med Wochenschr; 1994; 144(4):82-7. PubMed ID: 8023527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychologic and physiologic factors related to dyspnea in subjects with chronic obstructive pulmonary disease.
    Gift AG; Plaut SM; Jacox A
    Heart Lung; 1986 Nov; 15(6):595-601. PubMed ID: 3639857
    [No Abstract]   [Full Text] [Related]  

  • 34. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
    Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
    Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How can we assess the perception of induced dyspnea in chronic obstructive pulmonary disease?].
    Martínez Francés ME; Perpiñá Tordera M; Belloch Fuster A; Martínez Moragón EM; de Diego Damiá A
    Arch Bronconeumol; 2004 Apr; 40(4):149-54. PubMed ID: 15030728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing bronchodilator responsiveness in infants using partial expiratory flow-volume curves.
    Sheikh S; Castile R; Hayes J; McCoy K; Eid N
    Pediatr Pulmonol; 2003 Sep; 36(3):196-201. PubMed ID: 12910580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The usefulness of the Peak Flow Meter for assessing patients with acute respiratory disease].
    Alvarez Torices JC; Diego Domínguez F; Franch Nadal J; Alvarez Guisasola F; Pablo Pons ML
    An Med Interna; 1990 Nov; 7(11):570-4. PubMed ID: 2103210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind study of peak flow changes prior to emergency department visits.
    Murata GH; Kapsner CO; Lium DJ; Busby HK
    Respir Med; 1998 Jul; 92(7):936-41. PubMed ID: 10070567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of symptoms in asthma patients].
    Vogt M; Schandry R
    Pneumologie; 1995 May; 49(5):316-21. PubMed ID: 7610105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peak expiratory flow rate in normal pregnancy.
    Brancazio LR; Laifer SA; Schwartz T
    Obstet Gynecol; 1997 Mar; 89(3):383-6. PubMed ID: 9052590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.